Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2015 Sep 11;76(5):897–907. doi: 10.1007/s00280-015-2868-7

Table 1. Dose Level Summary.

Dose Level (mg/m2) # Patients # Patients w/ Crs 1, Grd 3/4 Tox # Patients w/ Crs 1, Grade 3/4 Tox Related Patients w/ DLT Total Completed Courses (# pts) Objective Responses
0.125 1 0 0 0 2 (1)

0.18 0
0.25 1 0 0 0 8 (1)
0.35 0
0.5 7 4 2 (Lymphopenia (1)) 1 (Alkaline Phosphatase) 12 (7)
0.7 4 3 2 0 14 (4)
1.0 3 1 0 0 5 (3)
1.4 19 14 10 1 (Febrile Neutropenia) 80 (19) PR: Lung, Bladder, Melanoma
2.0 5 4 4 2 (Febrile Neutropenia) 21 (5) PR: Lung

PR: Partial Response; Crs: Course